Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Genetic testing for hereditary breast and ovarian cancer: its effect on women

Genetic testing for hereditary breast and ovarian cancer: its effect on women

March 18, 2002

One in ten women opted to have prophylactic mastectomy and nearly half opted to have their ovaries removed in the year following genetic tests which showed they were at risk of hereditary breast and ovarian cancer (HBOC), a Belgian clinical psychologist reported at the 3rd European Breast Cancer Conference in Barcelona on Wednesday 20 March.

However Ms Erna Claes, who is studying the impact of predictive testing for HBOC, found that women who had been diagnosed as carriers were not significantly more or less distressed after the results of the predictive genetic testing than women who were found not to be carriers. Nor were there significant differences in distress levels before and after the results of genetic testing in either carriers or non-carriers, according to Ms Claes, a clinical psychologist at the Psychosocial Genetics Unit, Center for Human Genetics, Leuven in Belgium.




Instead the carriers took practical measures, following the screening recommendations and opting for regular medical examinations. About 10% had a prophylactic mastectomy within a year of the test result. Of the women who were carriers and aged over 35, 37% had had their ovaries removed (oophorectomy) before applying for predictive testing and 44% had prophylactic oophorectomy after the testing.

Ms Claes said there could be a number of reasons why the women reacted in the way that they did. "Within our current study group, only a minority of women have chosen to have a prophylactic mastectomy so far. The majority seem to find this procedure too far reaching or consider it will have too much impact on their lives, their partner or their sexual relations. However, long-term follow-up results are needed in order to see whether more women will choose to have prophylactic mastectomy after the predictive genetic test result. It is possible that what happens in their families could have an impact on their choice, for instance if their sister, mother or aunt is diagnosed with breast or ovarian cancer, or if a family member dies from cancer.

"On the other hand, I think more women chose to have a prophylactic oophorectomy after a positive test result because ovarian cancer is much harder to detect when in its early stages and much harder to treat successfully once it is more advanced; so the women opted for safety by having their ovaries removed, probably helped in their decision by the fact that the operation doesn't leave an obvious physical disfigurement in the way that a mastectomy does."

Ms Claes believes that the lack of change in distress levels between women who were carriers and non-carriers, and before and after the predictive genetic testing is due to a number of reasons. "The fact that the women received extensive counselling before and after the results may have made a difference. The fact that women who opt for predictive genetic testing may be worried about their risk, does not necessarily mean that this is the major or only reason to be tested. The most important arguments for testing are: wanting to know whether regular medical examinations of the breast or ovaries are needed or not, to decide about prophylactic surgery, wanting to know whether the children have an increased risk, reducing uncertainty. Moreover, psychological models suggest that distress due to perceived high risk or perceived severity of the disease can be diminished when there are possibilities available to control the threat. In addition, it may be that a self-selected group of women opt for predictive testing, namely those who can cope in some way with the genetic risk and who already have adjusted in some way to their increased risk. However, there may also be a tendency to minimize the emotional impact of the test result. The mean distress levels may not differ statistically, but this does not mean that there is not a vulnerable group. Therefore we try to delineate the subgroup of women who could be vulnerable to distress and look for variables that can predict distress.

"At the moment our study group of 38 women is too small to test these hypotheses, but when more data becomes available we will be able to get more insight into the factors associated with distress."

MW Communications



Related Ovarian Cancer Current Events and Ovarian Cancer News Articles Ovarian Cancer Current Events and Ovarian Cancer News RSS Ovarian Cancer Current Events and Ovarian Cancer News RSS
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.

American Dietetic Association Releases Updated Position Paper Promoting and Supporting Breastfeeding
The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.

Metals could forge new cancer drug
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.

Breast cancer patients with high risk gene diagnosed 6 years earlier than generation before
Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas M. D. Anderson Cancer Center.

Cancer Predisposition From Gene Variant Shows Strong Gender Bias
Cancer predisposition resulting from the presence of a specific gene variant shows a strong gender bias, researchers at the University of Cincinnati (UC) have demonstrated.

Medications Effective in Reducing Risks for Breast Cancer Can Also Cause Serious Side Effects
Three drugs that reduce a woman's chance of getting breast cancer also have been shown to cause adverse effects, according to a new report from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health & Human Services.

Scientists from University of Hawaii at Manoa find genetic marker
A new genetic marker associated with ovarian cancer risk was recently discovered by an international research group, led by scientists from the Cancer Research Genetic Epidemiology Unit in the United Kingdom.

New treatment in sight for ovarian cancer
In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells.

Young early stage ovarian cancer patients can preserve fertility
A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease.

Estrogen-Dependent Switch Tempers Killing Activity of Immune Cells
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses.
More Ovarian Cancer Current Events and Ovarian Cancer News Articles
Beating Ovarian Cancer: How To Overcome The Odds And Reclaim Your Life

Beating Ovarian Cancer: How To Overcome The Odds And Reclaim Your Life
by Chris Bledy (Author)

A diagnosis of Ovarian Cancer does not have to be a death sentence. Recent advances in medicine have made this once incurable disease treatable and manageable. You can beat advanced and even recurring, ovarian cancer. Simple but significant lifestyle changes can produce big results when it comes to healing.

Ovarian Cancer Awareness "Unite to Fight" Wristband Adult Size

Ovarian Cancer Awareness "Unite to Fight" Wristband Adult Size
by sci

Ovarian Cancer Awareness "Unite To Fight" Wristband adult size

A Guide to Survivorship for Women with Ovarian Cancer (A Johns Hopkins Press Health Book)

A Guide to Survivorship for Women with Ovarian Cancer (A Johns Hopkins Press Health Book)
by F. J. Montz MD KM FACOG FACS (Author), Robert E. Bristow MD FACOG (Author), Paula J. Anastasia RN MN OCN (Assistant)

This comprehensive guide to ovarian cancer offers a wealth of information to ease the physical, emotional, and psychic suffering of women with the disease. The authors -- two Johns Hopkins gynecologic oncologists and a gynecologic-oncology clinical nurse -- put particular emphasis on the concept of "survivorship," or living life well in the face of daunting uncertainties. They stress the importance of self-determination: the right of each patient to be informed, involved, and in control of her care.

Up-to-date information on diagnosis and treatment, including surgery, chemotherapy, radiation, pain management, and alternative therapies, forms the core of the book. But the authors' immense clinical experience also means they understand what women worry about and care about, and...

Ovarian Cancer Awareness 8" Ribbon Car Magnet

Ovarian Cancer Awareness 8" Ribbon Car Magnet
by sci

Ovarian Cancer Awareness 8" Ribbon Car Magnet

L'Oréal Paris Color of Hope OCRF (Ovarian Cancer Research Fund) Fundraising Sterling Silver Pavé CZ Bracelet

L'Oréal Paris Color of Hope OCRF (Ovarian Cancer Research Fund) Fundraising Sterling Silver Pavé CZ Bracelet
by Netaya

Sterling beauty with an equally beautiful message.

Its new, its exclusive and its absolutely beautiful. LOreal Paris is proud to present the Color of Hope Bracelet, a fundraising campaign, with 100% of all net profits ($5.00 per bracelet) benefiting The Ovarian Cancer Research Fund (OCRF).

Whether viewed as a circle representing life, endurance, love or seen as an "O" for ovarian cancer, the bracelet is a simple way for women everywhere to visibly and tangibly help in the fight against one of the world's most deadly of women's cancers.

The exclusive sterling silver Color of Hope bracelet features a rolo design chain with an "O" toggle clasp, adorned with pave cubic zirconias to give a beautiful brilliance. And to ensure that all women can adorn their wrists, the bracelet...

Ovarian Cancer Journeys: Survivors Share Their Stories To Help Others

Ovarian Cancer Journeys: Survivors Share Their Stories To Help Others
by Ayala Miron (Author)

"All of the research has reinforced that ovarian cancer is not a silent disease as was once thought and as is shown quite eloquently in this collection of stories.... The value of this collection of stories is that it helps raise awareness about symptoms, need for patient persistence, and the importance of being treated by a gynecologic oncologist."

Barbara A. Goff, MD
Professor and Co-Director, Division of Gynecologic Oncology University of Washington School of Medicine

Women of ages 17 to 78 join to tell their true stories.
Find out about the lessons they have learned along their ovarian cancer journeys; from symptoms to diagnosis, trough treatments, and survival.

Ovarian cancer facts:
Occurs in 1 out of 57 women 89% have symptoms at the early stages...

100 Questions & Answers About Ovarian Cancer, Second Edition

100 Questions & Answers About Ovarian Cancer, Second Edition
by Don S. Dizon (Author)

Whether you're a newly diagnosed ovarian cancer patient, a survivor, or a friend or relative of either, this book offers help. Completely updated, the new second edition of 100 Questions & Answers About Ovarian Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a gynecologic oncologist and a gynecologic surgeon, with actual patient commentary, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

Ovarian Cancer Awareness Long Sleeve T-shirt Large White

Ovarian Cancer Awareness Long Sleeve T-shirt Large White
by Shop Zeus



Ovarian Cancer Awareness Teal Ribbon Crystal Heart Necklace

Ovarian Cancer Awareness Teal Ribbon Crystal Heart Necklace
by CharmingChick

This is a beautiful new teal ribbon heart charm necklace that is the perfect way to show your support for Ovarian Cancer Awareness. The pendant measures about 5/8 of an inch tall and is made of genuine sterling silver. It has stunning teal Swarovski Crystal embedded in the front. Box chain measures about 16 inches long. This teal ribbon necklace would make a great gift or is a wonderful way to remember a loved one with Ovarian Cancer.

100 Pack Teal Blue Ribbon Temporary Tattoos for Ovarian Cervical Uterine Cancer Awareness

100 Pack Teal Blue Ribbon Temporary Tattoos for Ovarian Cervical Uterine Cancer Awareness
by Palmetto Fundraising

Show your courage and support! These teal ribbon tattoos are perfect for your next awareness event. These tattoos make great inspirational giveaways. 100 tattoos per package. Teal ribbon design with clear sides. Approximately 1.5" x 2". These cancer awareness favors are perfect for your awareness fundraisers or event.

© 2009 BrightSurf.com